Medistim ASA Working Capital to Net Assets Ratio
Medistim ASA working capital to net assets ratio. Medistim ASA (MEDI) has a Working Capital to Net Assets ratio of 68.9% as of June 2025. Working capital of Nkr264.33 Million (current assets of Nkr388.07 Million minus current liabilities of Nkr123.75 Million) is measured against net assets of Nkr383.81 Million. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Medistim ASA (2004–2024)
Working capital to net assets ratio of Medistim ASA from 2004 to 2024. This chart shows how Medistim ASA's Working Capital to Net Assets ratio has evolved across 21 annual periods from 2004 to 2024. As of June 2025, the ratio stands at 68.9%, reflecting working capital of Nkr264.33 Million against net assets of Nkr383.81 Million NOK. See MEDI defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Medistim ASA Working Capital to Net Assets Ratio by Year (2004–2024)
Medistim ASA working capital to net assets ratio by year from 2004 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Medistim ASA from 2004 to 2024, covering 21 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see MEDI current and non-current assets.
| Year | WC/NA Ratio | Working Capital (NOK) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 73.7% | Nkr321.76 Million | Nkr436.61 Million | Nkr429.13 Million | Nkr107.37 Million | ▼ -1.0 pp |
| 2023 | 74.7% | Nkr297.28 Million | Nkr397.94 Million | Nkr391.57 Million | Nkr94.28 Million | ▼ -3.1 pp |
| 2022 | 77.8% | Nkr286.07 Million | Nkr367.69 Million | Nkr385.89 Million | Nkr99.82 Million | ▲ +3.0 pp |
| 2021 | 74.8% | Nkr228.89 Million | Nkr306.05 Million | Nkr306.50 Million | Nkr77.60 Million | ▲ +2.3 pp |
| 2020 | 72.5% | Nkr186.31 Million | Nkr256.85 Million | Nkr245.79 Million | Nkr59.48 Million | ▲ +6.2 pp |
| 2019 | 66.3% | Nkr157.05 Million | Nkr236.86 Million | Nkr228.50 Million | Nkr71.45 Million | ▲ +1.0 pp |
| 2018 | 65.3% | Nkr135.07 Million | Nkr206.71 Million | Nkr190.45 Million | Nkr55.38 Million | ▼ -1.7 pp |
| 2017 | 67.0% | Nkr122.65 Million | Nkr182.98 Million | Nkr180.23 Million | Nkr57.58 Million | ▲ +7.5 pp |
| 2016 | 59.5% | Nkr99.15 Million | Nkr166.70 Million | Nkr146.95 Million | Nkr47.79 Million | ▼ -0.6 pp |
| 2015 | 60.1% | Nkr93.89 Million | Nkr156.16 Million | Nkr149.16 Million | Nkr55.27 Million | ▼ 0.0 pp |
| 2014 | 60.2% | Nkr83.68 Million | Nkr139.10 Million | Nkr134.96 Million | Nkr51.27 Million | ▲ +6.0 pp |
| 2013 | 54.2% | Nkr65.93 Million | Nkr121.64 Million | Nkr104.93 Million | Nkr39.00 Million | ▼ -2.6 pp |
| 2012 | 56.8% | Nkr65.41 Million | Nkr115.17 Million | Nkr98.64 Million | Nkr33.23 Million | ▼ -3.8 pp |
| 2011 | 60.6% | Nkr64.77 Million | Nkr106.89 Million | Nkr94.02 Million | Nkr29.25 Million | ▼ -5.6 pp |
| 2010 | 66.2% | Nkr71.35 Million | Nkr107.83 Million | Nkr97.13 Million | Nkr25.78 Million | ▲ +2.0 pp |
| 2009 | 64.1% | Nkr68.18 Million | Nkr106.29 Million | Nkr92.98 Million | Nkr24.80 Million | ▲ +11.4 pp |
| 2008 | 52.7% | Nkr50.34 Million | Nkr95.46 Million | Nkr85.18 Million | Nkr34.84 Million | ▲ +1.9 pp |
| 2007 | 50.8% | Nkr47.67 Million | Nkr93.83 Million | Nkr66.27 Million | Nkr18.59 Million | ▼ -8.6 pp |
| 2006 | 59.4% | Nkr43.99 Million | Nkr74.06 Million | Nkr69.76 Million | Nkr25.76 Million | ▲ +0.4 pp |
| 2005 | 59.0% | Nkr39.77 Million | Nkr67.41 Million | Nkr54.78 Million | Nkr15.01 Million | ▼ -19.2 pp |
| 2004 | 78.2% | Nkr48.28 Million | Nkr61.71 Million | Nkr59.22 Million | Nkr10.94 Million | — |